Loading...

Rapaport Mark

TitleChair
InstitutionUniversity of California Los Angeles
DepartmentDepartment of Psychiatry and Behavioral Science
Address8700 Beverly Blvd
Rm C-301Thalians
Los Angeles CA 90048
Phone310-423-2600
vCardDownload vCard
    Other Positions
    TitleProfessor In-Residence


    Collapse Research 
    Collapse Research Activities and Funding
    Omega-3 Fatty Acids for MDD with High Inflammation: A Personalized Approach
    NIH/NCCIH UG3AT008857Sep 15, 2015 - Jul 31, 2020
    Role: Principal Investigator
    Efficacy of swedish massage therapy on cancer-related fatigue in cancer survivors
    NIH/NCCIH R21AT007090May 1, 2013 - Apr 30, 2015
    Role: Principal Investigator
    Efficacy of Massage Therapy for the Treatment of Generalized Anxiety Disorder
    NIH/NCCIH R21AT004208Sep 30, 2010 - Aug 31, 2014
    Role: Principal Investigator
    Omega-3 Fatty Acids for Treatment of Major Depressive Disorder
    NIH/NIMH R01MH073765Feb 1, 2006 - Jan 31, 2012
    Role: Co-Principal Investigator
    A Model for the Mechanism of Action of Massage
    NIH/NCCIH R21AT002751Jun 1, 2005 - Mar 31, 2009
    Role: Principal Investigator
    Pharmacotherapy for Minor Depression
    NIH/NIMH R01MH061757Sep 17, 2001 - Aug 31, 2006
    Role: Principal Investigator
    SCHIZOPHRENIA AND IMMUNE ACTIVATION
    NIH/NIMH R29MH049746Feb 1, 1997 - Jan 31, 2003
    Role: Principal Investigator
    PSYCHOBIOLOGICAL STUDY OF PSYCHIATRIC DISORDERS
    NIH/NIMH P30MH030914Sep 29, 1977 - Dec 31, 2003
    Role: Co-Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Rakofsky J, Rapaport M. Mood Disorders. Continuum (Minneap Minn). 2018 Jun; 24(3, BEHAVIORAL NEUROLOGY AND PSYCHIATRY):804-827. PMID: 29851879.
      View in: PubMed
    2. Kinkead B, Schettler PJ, Larson ER, Carroll D, Sharenko M, Nettles J, Edwards SA, Miller AH, Torres MA, Dunlop BW, Rakofsky JJ, Rapaport M. Massage therapy decreases cancer-related fatigue: Results from a randomized early phase trial. Cancer. 2018 Feb 01; 124(3):546-554. PMID: 29044466.
      View in: PubMed
    3. Fava M, Freeman MP, Flynn M, Hoeppner BB, Shelton R, Iosifescu DV, Murrough JW, Mischoulon D, Cusin C, Rapaport M, Dunlop BW, Trivedi MH, Jha M, Sanacora G, Hermes G, Papakostas GI. Double-blind, proof-of-concept (POC) trial of Low-Field Magnetic Stimulation (LFMS) augmentation of antidepressant therapy in treatment-resistant depression (TRD). Brain Stimul. 2018 Jan - Feb; 11(1):75-84. PMID: 29030111.
      View in: PubMed
    4. Griffiths CEM, Fava M, Miller AH, Russell J, Ball SG, Xu W, Acharya N, Rapaport M. Impact of Ixekizumab Treatment on Depressive Symptoms and Systemic Inflammation in Patients with Moderate-to-Severe Psoriasis: An Integrated Analysis of Three Phase 3 Clinical Studies. Psychother Psychosom. 2017; 86(5):260-267. PMID: 28903122.
      View in: PubMed
    5. Bremner JD, Rapaport M. Vagus Nerve Stimulation: Back to the Future. Am J Psychiatry. 2017 07 01; 174(7):609-610. PMID: 28669203.
      View in: PubMed
    6. Dunlop BW, Gray J, Rapaport M. Transdiagnostic Clinical Global Impression Scoring for Routine Clinical Settings. Behav Sci (Basel). 2017 Jun 27; 7(3). PMID: 28653978.
      View in: PubMed
    7. Rommelfanger KS, Factor SA, LaRoche S, Rosen P, Young R, Rapaport M. Disentangling Stigma from Functional Neurological Disorders: Conference Report and Roadmap for the Future. Front Neurol. 2017; 8:106. PMID: 28424653.
      View in: PubMed
    8. Dunlop BW, Rapaport M. When Should a Patient Be Declared Recovered From a Major Depressive Episode? J Clin Psychiatry. 2016 Aug; 77(8):e1026-8. PMID: 27561150.
      View in: PubMed
    9. Rapaport M, Schettler P, Larson ER, Edwards SA, Dunlop BW, Rakofsky JJ, Kinkead B. Acute Swedish Massage Monotherapy Successfully Remediates Symptoms of Generalized Anxiety Disorder: A Proof-of-Concept, Randomized Controlled Study. J Clin Psychiatry. 2016 Jul; 77(7):e883-91. PMID: 27464321.
      View in: PubMed
    10. Miller BJ, Goldsmith DR, Paletta N, Wong J, Kandhal P, Black C, Rapaport M, Buckley PF. Parental type 2 diabetes in patients with non-affective psychosis. Schizophr Res. 2016 08; 175(1-3):223-225. PMID: 27156239; PMCID: PMC4958496.
    11. Rakofsky JJ, Cotes RO, McDonald WM, Schwartz AC, Rapaport M. Beyond the Psychiatric Horizon: Preparing Residents for the Twenty-First Century. Acad Psychiatry. 2017 Feb; 41(1):125-131. PMID: 26955812.
      View in: PubMed
    12. Rapaport M. Lori L. Altshuler, MD 1957-2015. J Clin Psychiatry. 2016 Mar; 77(3):333. PMID: 27046306.
      View in: PubMed
    13. Magen J, Rapaport M. Psychiatry Departments Under Constrained Funding Mechanisms or What Is a Chairperson to Do? Acad Psychiatry. 2016 Dec; 40(6):869-873. PMID: 26758737.
      View in: PubMed
    14. Rapaport M. Patients' preference for complementary and alternative medicine presents challenges for research. J Clin Psychiatry. 2015 Jul; 76(7):e886-7. PMID: 26231016.
      View in: PubMed
    15. Dunlop BW, Rapaport M. Antidepressant signal detection in the clinical trials vortex. J Clin Psychiatry. 2015 May; 76(5):e657-9. PMID: 26035201.
      View in: PubMed
    16. Miller BJ, Kandhal P, Rapaport M, Mellor A, Buckley P. Total and differential white blood cell counts, high-sensitivity C-reactive protein, and cardiovascular risk in non-affective psychoses. Brain Behav Immun. 2015 Mar; 45:28-35. PMID: 25542737.
      View in: PubMed
    17. Walker ER, Berry FW, Citron T, Fitzgerald J, Rapaport M, Stephens B, Druss BG. Psychiatric workforce needs and recommendations for the community mental health system: a state needs assessment. Psychiatr Serv. 2015 Feb 01; 66(2):115-7. PMID: 25642608; PMCID: PMC4386683.
    18. Saah T, Garlow SJ, Rapaport M. Provide optimized antidepressant monotherapy with multiple drugs before considering antidepressant polypharmacy. Shanghai Arch Psychiatry. 2014 Dec; 26(6):360-2. PMID: 25642111; PMCID: PMC4311110.
    19. Miller BJ, Culpepper N, Rapaport M. C-reactive protein levels in schizophrenia: a review and meta-analysis. Clin Schizophr Relat Psychoses. 2014 Jan; 7(4):223-30. PMID: 23428789.
      View in: PubMed
    20. Rakofsky JJ, Schettler PJ, Kinkead BL, Frank E, Judd LL, Kupfer DJ, Rush AJ, Thase ME, Yonkers KA, Rapaport M. The prevalence and severity of depressive symptoms along the spectrum of unipolar depressive disorders: a post hoc analysis. J Clin Psychiatry. 2013 Nov; 74(11):1084-91. PMID: 24330894.
      View in: PubMed
    21. Garlow SJ, Kinkead B, Thase ME, Judd LL, Rush AJ, Yonkers KA, Kupfer DJ, Frank E, Schettler PJ, Rapaport M. Fluoxetine increases suicide ideation less than placebo during treatment of adults with minor depressive disorder. J Psychiatr Res. 2013 Sep; 47(9):1199-203. PMID: 23786912; PMCID: PMC3729337.
    22. Edwards E, Mischoulon D, Rapaport M, Stussman B, Weber W. Building an evidence base in complementary and integrative healthcare for child and adolescent psychiatry. Child Adolesc Psychiatr Clin N Am. 2013 Jul; 22(3):509-29, vii. PMID: 23806317.
      View in: PubMed
    23. Pato MT, Sobell JL, Medeiros H, Abbott C, Sklar BM, Buckley PF, Bromet EJ, Escamilla MA, Fanous AH, Lehrer DS, Macciardi F, Malaspina D, McCarroll SA, Marder SR, Moran J, Morley CP, Nicolini H, Perkins DO, Purcell SM, Rapaport M, Sklar P, Smoller JW, Knowles JA. The genomic psychiatry cohort: partners in discovery. Am J Med Genet B Neuropsychiatr Genet. 2013 Jun; 162B(4):306-12. PMID: 23650244.
      View in: PubMed
    24. Glick ID, Zisook S, Rapaport M. Teaching the teacher: a report from the third annual American Society of Clinical Psychopharmacology teaching session. J Clin Psychiatry. 2013 Mar; 74(3):262-4. PMID: 23561232.
      View in: PubMed
    25. Dunlop BW, Rakofsky JJ, Rapaport M. A simple question answered: adding moderate-dosage lithium does not help patients with bipolar disorder. Am J Psychiatry. 2013 Jan; 170(1):9-11. PMID: 23288384.
      View in: PubMed
    26. Papakostas GI, Vitolo OV, Ishak WW, Rapaport M, Zajecka JM, Kinrys G, Mischoulon D, Lipkin SH, Hails KA, Abrams J, Ward SG, Meisner A, Schoenfeld DA, Shelton RC, Winokur A, Okasha MS, Bari MA, Fava M. A 12-week, randomized, double-blind, placebo-controlled, sequential parallel comparison trial of ziprasidone as monotherapy for major depressive disorder. J Clin Psychiatry. 2012 Dec; 73(12):1541-7. PMID: 23290327.
      View in: PubMed
    27. Rapaport M, Bazzetta J, McAdams LA, Patterson T, Jeste DV. Validation of the Scale of Functioning in Older Outpatients With Schizophrenia. Am J Geriatr Psychiatry. 1996 Summer; 4(3):218-228. PMID: 28531080.
      View in: PubMed
    28. Rapaport M, Schettler P, Bresee C. A preliminary study of the effects of repeated massage on hypothalamic-pituitary-adrenal and immune function in healthy individuals: a study of mechanisms of action and dosage. J Altern Complement Med. 2012 Aug; 18(8):789-97. PMID: 22775448; PMCID: PMC3419840.
    29. Ishak WW, Balayan K, Bresee C, Greenberg JM, Fakhry H, Christensen S, Rapaport M. A descriptive analysis of quality of life using patient-reported measures in major depressive disorder in a naturalistic outpatient setting. Qual Life Res. 2013 Apr; 22(3):585-96. PMID: 22544416.
      View in: PubMed
    30. Miller BJ, Culpepper N, Rapaport M, Buckley P. Prenatal inflammation and neurodevelopment in schizophrenia: a review of human studies. Prog Neuropsychopharmacol Biol Psychiatry. 2013 Apr 05; 42:92-100. PMID: 22510462.
      View in: PubMed
    31. Kane JM, Hill LD, Kinon BJ, Potter WZ, Rapaport M, Schooler NR. New Clinical Drug Evaluation Unit (NCDEU) annual meeting: a great opportunity for early career psychiatrists. J Clin Psychiatry. 2012 Apr; 73(4):504-5. PMID: 22579149.
      View in: PubMed
    32. Targum SD, Little JA, Lopez E, Demartinis N, Rapaport M, Ereshefsky L. Application of external review for subject selection in a schizophrenia trial. J Clin Psychopharmacol. 2012 Apr; 32(2):825-6. PMID: 22388170.
      View in: PubMed
    33. Fan A, Berg A, Bresee C, Glassman LH, Rapaport M. Allopurinol augmentation in the outpatient treatment of bipolar mania: a pilot study. Bipolar Disord. 2012 Mar; 14(2):206-10. PMID: 22420596.
      View in: PubMed
    34. Gertsik L, Poland RE, Bresee C, Rapaport M. Omega-3 fatty acid augmentation of citalopram treatment for patients with major depressive disorder. J Clin Psychopharmacol. 2012 Feb; 32(1):61-4. PMID: 22198441; PMCID: PMC3375825.
    35. Vilhauer JS, Young S, Kealoha C, Borrmann J, IsHak WW, Rapaport M, Hartoonian N, Mirocha J. Treating major depression by creating positive expectations for the future: a pilot study for the effectiveness of future-directed therapy (FDT) on symptom severity and quality of life. CNS Neurosci Ther. 2012 Feb; 18(2):102-9. PMID: 21615882.
      View in: PubMed
    36. Ishak WW, Ha K, Kapitanski N, Bagot K, Fathy H, Swanson B, Vilhauer J, Balayan K, Bolotaulo NI, Rapaport M. The impact of psychotherapy, pharmacotherapy, and their combination on quality of life in depression. Harv Rev Psychiatry. 2011 Nov-Dec; 19(6):277-89. PMID: 22098324.
      View in: PubMed
    37. Turner N, Macfadden W, Anand R, Khanna S, Rapaport M, Haskins JT, Turkoz I, Alphs L. Use of a relapse monitoring board: an independent assessment for determining relapse in clinical trials for bipolar disorder. Innov Clin Neurosci. 2011 Oct; 8(10):19-24. PMID: 22132367.
      View in: PubMed
    38. IsHak WW, Greenberg JM, Balayan K, Kapitanski N, Jeffrey J, Fathy H, Fakhry H, Rapaport M. Quality of life: the ultimate outcome measure of interventions in major depressive disorder. Harv Rev Psychiatry. 2011 Sep-Oct; 19(5):229-39. PMID: 21916825.
      View in: PubMed
    39. Bokarius A, Ha K, Poland R, Bokarius V, Rapaport M, Ishak WW. Attitude toward humor in patients experiencing depressive symptoms. Innov Clin Neurosci. 2011 Sep; 8(9):20-3. PMID: 22010061; PMCID: PMC3196329.
    40. Wisner KL, Conley RR, Taylor SF, Kosten T, Rapaport M, Brown LS. Researcher experiences with IRBs: a survey of members of the American College of Neuropsychopharmacology. IRB. 2011 Sep-Oct; 33(5):14-20. PMID: 22043746.
      View in: PubMed
    41. Rapaport M, Nierenberg AA, Howland R, Dording C, Schettler PJ, Mischoulon D. The treatment of minor depression with St. John's Wort or citalopram: failure to show benefit over placebo. J Psychiatr Res. 2011 Jul; 45(7):931-41. PMID: 21632064; PMCID: PMC3137264.
    42. Yager J, Silverman JJ, Rapaport M. Adapting to decreased industry support of CME: lifelong education in an "industry-lite" world. Acad Psychiatry. 2011 Mar-Apr; 35(2):101-5. PMID: 21403160.
      View in: PubMed
    43. Freeman MP, Rapaport M. Omega-3 fatty acids and depression: from cellular mechanisms to clinical care. J Clin Psychiatry. 2011 Feb; 72(2):258-9. PMID: 21382308.
      View in: PubMed
    44. Rapaport M, Schettler P, Breese C. A preliminary study of the effects of a single session of Swedish massage on hypothalamic-pituitary-adrenal and immune function in normal individuals. J Altern Complement Med. 2010 Oct; 16(10):1079-88. PMID: 20809811.
      View in: PubMed
    45. Nierenberg AA, Rapaport M, Schettler PJ, Howland RH, Smith JA, Edwards D, Schneider T, Mischoulon D. Deficits in psychological well-being and quality-of-life in minor depression: implications for DSM-V. CNS Neurosci Ther. 2010 Aug; 16(4):208-16. PMID: 20236139.
      View in: PubMed
    46. Robinson D, Aguilar D, Schoenwetter M, Dubois R, Russak S, Ramsey-Goldman R, Navarra S, Hsu B, Revicki D, Cella D, Rapaport M, Renahan K, Ress R, Wallace D, Weisman M. Impact of systemic lupus erythematosus on health, family, and work: the patient perspective. Arthritis Care Res (Hoboken). 2010 Feb; 62(2):266-73. PMID: 20191527.
      View in: PubMed
    47. Rapaport M, Bresee C. Serial mitogen-stimulated cytokine production from continuously ill patients with schizophrenia. Neuropsychopharmacology. 2010 Jan; 35(2):428-34. PMID: 19759532; PMCID: PMC2794914.
    48. IsHak WW, Davis M, Jeffrey J, Balayan K, Pechnick RN, Bagot K, Rapaport M. The role of dopaminergic agents in improving quality of life in major depressive disorder. Curr Psychiatry Rep. 2009 Dec; 11(6):503-8. PMID: 19909674.
      View in: PubMed
    49. Rapaport M. Beyond acute treatment of depressive disorders. J Clin Psychiatry. 2009 Jul; 70(7):e21. PMID: 19653967.
      View in: PubMed
    50. Rapaport M. Helping patients with depression achieve wellness. J Clin Psychiatry. 2009 May; 70(5):e11. PMID: 19552858.
      View in: PubMed
    51. Bresee C, Rapaport M. Persistently increased serum soluble interleukin-2 receptors in continuously ill patients with schizophrenia. Int J Neuropsychopharmacol. 2009 Jul; 12(6):861-5. PMID: 19366488.
      View in: PubMed
    52. Rapaport M. Future drugs for the treatment of depression: the need to look beyond monoamine systems. CNS Spectr. 2009 Mar; 14(3 Suppl 5):14-6. PMID: 19407719.
      View in: PubMed
    53. Rapaport M. ECP news. The new investigator program at the NCDEU meeting: opportunities found for all. J Clin Psychiatry. 2009 Jan; 70(1):130. PMID: 19222983.
      View in: PubMed
    54. Rapaport M, Hales DJ. Qualifications for recertification: an important but evolving set of standards. J Clin Psychiatry. 2008 11; 69(11):1829, commentary 1829-30. PMID: 19200431.
      View in: PubMed
    55. Rapaport M, Lydiard RB, Pitts CD, Schaefer D, Bartolic EI, Iyengar M, Carfagno M, Lipschitz A. Low doses of controlled-release paroxetine in the treatment of late-life depression: a randomized, placebo-controlled trial. J Clin Psychiatry. 2009 Jan; 70(1):46-57. PMID: 19026248.
      View in: PubMed
    56. Szeftel R, Hakak R, Meyer S, Naqvi S, Sulman-Smith H, Delrahim K, Rapaport M. Training psychiatric residents and fellows in a telepsychiatry clinic: a supervision model. Acad Psychiatry. 2008 Sep-Oct; 32(5):393-9. PMID: 18945978.
      View in: PubMed
    57. Howland RH, Schettler PJ, Rapaport M, Mischoulon D, Schneider T, Fasiczka A, Delrahiem K, Maddux R, Lightfoot M, Nierenberg AA. Clinical features and functioning of patients with minor depression. Psychother Psychosom. 2008; 77(6):384-9. PMID: 18716424.
      View in: PubMed
    58. Marangell LB, Dennehy EB, Miyahara S, Wisniewski SR, Bauer MS, Rapaport M, Allen MH. The functional impact of subsyndromal depressive symptoms in bipolar disorder: data from STEP-BD. J Affect Disord. 2009 Apr; 114(1-3):58-67. PMID: 18708263; PMCID: PMC2704060.
    59. Gyulai L, Bauer MS, Marangell LB, Dennehy EB, Thase ME, Otto MW, Zhang H, Wisniewski SR, Miklowitz DJ, Rapaport M, Baldassano CF, Sachs GS. Correlates of functioning in bipolar disorder. Psychopharmacol Bull. 2008; 41(4):51-64. PMID: 19015629.
      View in: PubMed
    60. Rapaport M, Thase ME. Translating the evidence on atypical depression into clinical practice. J Clin Psychiatry. 2007 Apr; 68(4):e11. PMID: 17474801.
      View in: PubMed
    61. Rapaport M. Dietary restrictions and drug interactions with monoamine oxidase inhibitors: the state of the art. J Clin Psychiatry. 2007; 68 Suppl 8:42-6. PMID: 17640157.
      View in: PubMed
    62. Hyman Rapaport M. Translating the evidence on atypical depression into clinical practice. J Clin Psychiatry. 2007; 68 Suppl 3:31-6. PMID: 17348765.
      View in: PubMed
    63. Rapaport M, Skarky SB, Katzelnick DJ, Dewester JN, Harper JM, McCrary KE. Time to response in generalized anxiety disorder in a naturalistic setting: combination therapy with alprazolam orally disintegrating tablets and serotonin reuptake inhibitors compared to serotonin reuptake inhibitors alone. Psychiatry (Edgmont). 2006 Dec; 3(12):50-9. PMID: 20877556; PMCID: PMC2945897.
    64. Shelton RC, Haman KL, Rapaport M, Kiev A, Smith WT, Hirschfeld RM, Lydiard RB, Zajecka JM, Dunner DL. A randomized, double-blind, active-control study of sertraline versus venlafaxine XR in major depressive disorder. J Clin Psychiatry. 2006 Nov; 67(11):1674-81. PMID: 17196045.
      View in: PubMed
    65. Freedman R, Lewis DA, Michels R, Pine DS, Schultz SK, Tamminga C, Patterson SL, McIntyre JS, Goldman HH, Yudofsky SC, Hales RE, Rapaport M, Hales D, Krajeski J, Kupfer DJ, Badaracco MA, Scully JH. Conflict of interest, round 2. Am J Psychiatry. 2006 Sep; 163(9):1481-3. PMID: 16946167.
      View in: PubMed
    66. Culpepper L, Judd CR, Moller MD, Nemeroff CB, Rapaport M, Ciraulo DA. Clinicians on the front line: active management of depression and anxiety in primary care. JAAPA. 2006 Jul; Suppl:4-21; quiz 22. PMID: 16999330.
      View in: PubMed
    67. Rapaport M, Gharabawi GM, Canuso CM, Mahmoud RA, Keller MB, Bossie CA, Turkoz I, Lasser RA, Loescher A, Bouhours P, Dunbar F, Nemeroff CB. Effects of risperidone augmentation in patients with treatment-resistant depression: Results of open-label treatment followed by double-blind continuation. Neuropsychopharmacology. 2006 Nov; 31(11):2505-13. PMID: 16760927.
      View in: PubMed
    68. Rowe SK, Rapaport M. Classification and treatment of sub-threshold depression. Curr Opin Psychiatry. 2006 Jan; 19(1):9-13. PMID: 16612172.
      View in: PubMed
    69. Rush AJ, Marangell LB, Sackeim HA, George MS, Brannan SK, Davis SM, Howland R, Kling MA, Rittberg BR, Burke WJ, Rapaport M, Zajecka J, Nierenberg AA, Husain MM, Ginsberg D, Cooke RG. Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled acute phase trial. Biol Psychiatry. 2005 Sep 01; 58(5):347-54. PMID: 16139580.
      View in: PubMed
    70. Bresee CJ, Delrahim K, Maddux RE, Dolnak D, Ahmadpour O, Rapaport M. The effects of celecoxib augmentation on cytokine levels in schizophrenia. Int J Neuropsychopharmacol. 2006 Jun; 9(3):343-8. PMID: 16035956.
      View in: PubMed
    71. Rapaport M, Delrahim KK, Bresee CJ, Maddux RE, Ahmadpour O, Dolnak D. Celecoxib augmentation of continuously ill patients with schizophrenia. Biol Psychiatry. 2005 Jun 15; 57(12):1594-6. PMID: 15953498.
      View in: PubMed
    72. Rapaport M, Clary C, Fayyad R, Endicott J. Quality-of-life impairment in depressive and anxiety disorders. Am J Psychiatry. 2005 Jun; 162(6):1171-8. PMID: 15930066.
      View in: PubMed
    73. Khan A, Kolts RL, Rapaport M, Krishnan KR, Brodhead AE, Browns WA. Magnitude of placebo response and drug-placebo differences across psychiatric disorders. Psychol Med. 2005 May; 35(5):743-9. PMID: 15918351.
      View in: PubMed
    74. Akiskal HS, Mendlowicz MV, Jean-Louis G, Rapaport M, Kelsoe JR, Gillin JC, Smith TL. TEMPS-A: validation of a short version of a self-rated instrument designed to measure variations in temperament. J Affect Disord. 2005 Mar; 85(1-2):45-52. PMID: 15780675.
      View in: PubMed
    75. Mendlowicz MV, Akiskal HS, Kelsoe JR, Rapaport M, Jean-Louis G, Gillin JC. Temperament in the clinical differentiation of depressed bipolar and unipolar major depressive patients. J Affect Disord. 2005 Feb; 84(2-3):219-23. PMID: 15708419.
      View in: PubMed
    76. Ishak WW, Rapaport M, Gotto JG. The effectiveness of atypical antipsychotic medications in depressive disorders. Curr Psychiatry Rep. 2004 Dec; 6(6):422-4. PMID: 15538989.
      View in: PubMed
    77. Haynes PL, McQuaid JR, Kelsoe J, Rapaport M, Gillin JC. Affective state and EEG sleep profile in response to rapid tryptophan depletion in recently recovered nonmedicated depressed individuals. J Affect Disord. 2004 Dec; 83(2-3):253-62. PMID: 15555723.
      View in: PubMed
    78. Lenert LA, Sturley AP, Rapaport M, Chavez S, Mohr PE, Rupnow M. Public preferences for health states with schizophrenia and a mapping function to estimate utilities from positive and negative symptom scale scores. Schizophr Res. 2004 Nov 01; 71(1):155-65. PMID: 15374583.
      View in: PubMed
    79. Judd LL, Rapaport M, Yonkers KA, Rush AJ, Frank E, Thase ME, Kupfer DJ, Plewes JM, Schettler PJ, Tollefson G. Randomized, placebo-controlled trial of fluoxetine for acute treatment of minor depressive disorder. Am J Psychiatry. 2004 Oct; 161(10):1864-71. PMID: 15465984.
      View in: PubMed
    80. Rapaport M, Bose A, Zheng H. Escitalopram continuation treatment prevents relapse of depressive episodes. J Clin Psychiatry. 2004 Jan; 65(1):44-9. PMID: 14744167.
      View in: PubMed
    81. Maddux RE, Delrahim KK, Rapaport M. Quality of life in geriatric patients with mood and anxiety disorders. CNS Spectr. 2003 Dec; 8(12 Suppl 3):35-47. PMID: 14978462.
      View in: PubMed
    82. Caligiuri MP, Gentili V, Eberson S, Kelsoe J, Rapaport M, Gillin JC. A quantitative neuromotor predictor of antidepressant non-response in patients with major depression. J Affect Disord. 2003 Nov; 77(2):135-41. PMID: 14607390.
      View in: PubMed
    83. Rapaport M, Schneider LS, Dunner DL, Davies JT, Pitts CD. Efficacy of controlled-release paroxetine in the treatment of late-life depression. J Clin Psychiatry. 2003 Sep; 64(9):1065-74. PMID: 14628982.
      View in: PubMed
    84. Wang XF, Wang D, Zhu W, Delrahim KK, Dolnak D, Rapaport M. Studies characterizing 60 kda autoantibodies in subjects with schizophrenia. Biol Psychiatry. 2003 Mar 01; 53(5):361-75. PMID: 12614989.
      View in: PubMed
    85. Rapaport M, Maddux RE. Challenges in the development of clinical trials for major depressive disorder: lessons learned from trials in minor depression. Dialogues Clin Neurosci. 2002 Dec; 4(4):402-7. PMID: 22034443; PMCID: PMC3181702.
    86. Evans L, Golshan S, Kelsoe J, Rapaport M, Resovsky K, Sutton L, Gillin JC. Effects of rapid tryptophan depletion on sleep electroencephalogram and mood in subjects with partially remitted depression on bupropion. Neuropsychopharmacology. 2002 Dec; 27(6):1016-26. PMID: 12464458.
      View in: PubMed
    87. Pollack MH, Rapaport M, Fayyad R, Otto MW, Nierenberg AA, Clary CM. Early improvement predicts endpoint remission status in sertraline and placebo treatments of panic disorder. J Psychiatr Res. 2002 Jul-Aug; 36(4):229-36. PMID: 12191627.
      View in: PubMed
    88. Rapaport M, Judd LL, Schettler PJ, Yonkers KA, Thase ME, Kupfer DJ, Frank E, Plewes JM, Tollefson GD, Rush AJ. A descriptive analysis of minor depression. Am J Psychiatry. 2002 Apr; 159(4):637-43. PMID: 11925303.
      View in: PubMed
    89. Mendlowicz MV, Rapaport M, Fontenelle L, Jean-Louis G, De Moraes TM. Amnesia and neonaticide. Am J Psychiatry. 2002 Mar; 159(3):498-9. PMID: 11870035.
      View in: PubMed
    90. Rapaport M, Endicott J, Clary CM. Posttraumatic stress disorder and quality of life: results across 64 weeks of sertraline treatment. J Clin Psychiatry. 2002 Jan; 63(1):59-65. PMID: 11838628.
      View in: PubMed
    91. Delrahim KK, Maddux R, Rapaport M. Long-term antidepressant treatment. Psychopharmacol Bull. 2002; 36(4):26-38. PMID: 12858141.
      View in: PubMed